Cargando…

Thyroiditis After COVID-19 mRNA Vaccine: A Case Series

BACKGROUND: Although SARS-CoV-2 virus infection has been reported to cause subacute thyroiditis, the mRNA vaccine for SARS-CoV-2 is suspected to induce thyroiditis with thyrotoxicosis. CASE REPORT: : We describe 3 patients with no history of thyroid disease who presented with symptomatic, biochemica...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandya, Manthan, Thota, Geethika, Wang, Xiangbing, Luo, Hongxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Clinical Endocrinology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675183/
https://www.ncbi.nlm.nih.gov/pubmed/34934810
http://dx.doi.org/10.1016/j.aace.2021.12.002
_version_ 1784615828906311680
author Pandya, Manthan
Thota, Geethika
Wang, Xiangbing
Luo, Hongxiu
author_facet Pandya, Manthan
Thota, Geethika
Wang, Xiangbing
Luo, Hongxiu
author_sort Pandya, Manthan
collection PubMed
description BACKGROUND: Although SARS-CoV-2 virus infection has been reported to cause subacute thyroiditis, the mRNA vaccine for SARS-CoV-2 is suspected to induce thyroiditis with thyrotoxicosis. CASE REPORT: : We describe 3 patients with no history of thyroid disease who presented with symptomatic, biochemical, and radiological evidence of thyroiditis with thyrotoxicosis, 10 to 20 days after receiving either Pfizer Bio-NTech or Moderna COVID-19 mRNA vaccines. All patients presented with thyrotoxicosis but with negative thyroid-stimulating immunoglobulins for Graves disease and no autonomous nodules. Two patients underwent thyroid uptake scans that confirmed thyroiditis. One patient had significantly increased erythrocyte sedimentation rate and interleukin-6. All patients showed improvement in symptoms with nonsteroidal anti-inflammatory drugs, and 1 patient eventually required steroids for symptom control. DISCUSSION: The mRNA vaccine for SARS-CoV-2 was associated with thyroiditis and led to thyrotoxicosis. Elevated proinflammatory markers and cytokines after vaccines may play a major role. CONCLUSION: Our case series report highlights a possible relationship between the COVID-19 mRNA vaccine and thyroiditis with thyrotoxicosis, which has not been recognized by health providers.
format Online
Article
Text
id pubmed-8675183
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Association of Clinical Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-86751832021-12-17 Thyroiditis After COVID-19 mRNA Vaccine: A Case Series Pandya, Manthan Thota, Geethika Wang, Xiangbing Luo, Hongxiu AACE Clin Case Rep Case Report BACKGROUND: Although SARS-CoV-2 virus infection has been reported to cause subacute thyroiditis, the mRNA vaccine for SARS-CoV-2 is suspected to induce thyroiditis with thyrotoxicosis. CASE REPORT: : We describe 3 patients with no history of thyroid disease who presented with symptomatic, biochemical, and radiological evidence of thyroiditis with thyrotoxicosis, 10 to 20 days after receiving either Pfizer Bio-NTech or Moderna COVID-19 mRNA vaccines. All patients presented with thyrotoxicosis but with negative thyroid-stimulating immunoglobulins for Graves disease and no autonomous nodules. Two patients underwent thyroid uptake scans that confirmed thyroiditis. One patient had significantly increased erythrocyte sedimentation rate and interleukin-6. All patients showed improvement in symptoms with nonsteroidal anti-inflammatory drugs, and 1 patient eventually required steroids for symptom control. DISCUSSION: The mRNA vaccine for SARS-CoV-2 was associated with thyroiditis and led to thyrotoxicosis. Elevated proinflammatory markers and cytokines after vaccines may play a major role. CONCLUSION: Our case series report highlights a possible relationship between the COVID-19 mRNA vaccine and thyroiditis with thyrotoxicosis, which has not been recognized by health providers. American Association of Clinical Endocrinology 2021-12-16 /pmc/articles/PMC8675183/ /pubmed/34934810 http://dx.doi.org/10.1016/j.aace.2021.12.002 Text en © 2022 AACE. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Pandya, Manthan
Thota, Geethika
Wang, Xiangbing
Luo, Hongxiu
Thyroiditis After COVID-19 mRNA Vaccine: A Case Series
title Thyroiditis After COVID-19 mRNA Vaccine: A Case Series
title_full Thyroiditis After COVID-19 mRNA Vaccine: A Case Series
title_fullStr Thyroiditis After COVID-19 mRNA Vaccine: A Case Series
title_full_unstemmed Thyroiditis After COVID-19 mRNA Vaccine: A Case Series
title_short Thyroiditis After COVID-19 mRNA Vaccine: A Case Series
title_sort thyroiditis after covid-19 mrna vaccine: a case series
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675183/
https://www.ncbi.nlm.nih.gov/pubmed/34934810
http://dx.doi.org/10.1016/j.aace.2021.12.002
work_keys_str_mv AT pandyamanthan thyroiditisaftercovid19mrnavaccineacaseseries
AT thotageethika thyroiditisaftercovid19mrnavaccineacaseseries
AT wangxiangbing thyroiditisaftercovid19mrnavaccineacaseseries
AT luohongxiu thyroiditisaftercovid19mrnavaccineacaseseries